Ivan Cheung

CIK: 0002042690

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LXRX

LEXICON PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

LXRX
LEXICON PHARMACEUTICALS, INC.
Jun 3, 2026
Exercise(M)
Direct
89.3K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
May 1, 2026
Award(A)
Restricted Stock Units
Direct
35.7K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
May 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
43.5K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
Jun 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
103.8K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
Jun 3, 2025
Award(A)
Restricted Stock Units
Direct
89.3K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
Dec 2, 2024
Award(A)
Stock Option (Right to Buy)
Direct
186.7K shares-

		Type	Shares	Price		Ownership
Jun 3, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Exercise(M)	89,312	-	$0	Direct
May 1, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Award(A) Restricted Stock Units	35,714	-	-	Direct
May 1, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	43,478	-	-	Direct
Jun 3, 2025	LXRX LEXICON PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	103,806	-	-	Direct
Jun 3, 2025	LXRX LEXICON PHARMACEUTICALS, INC.	Award(A) Restricted Stock Units	89,312	-	-	Direct
Dec 2, 2024	LXRX LEXICON PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	186,685	-	-	Direct

1-6 of 6 transactions

About Cheung Ivan

Cheung Ivan (SEC CIK 0002042690) files insider reports with the SEC as Director of LEXICON PHARMACEUTICALS, INC. (LXRX).

Signal8 holds 5 ownership filings by Cheung Ivan (1 Form 3, 4 Form 4), filed between Dec 2, 2024 and Jun 4, 2026. Those filings report 6 transactions, from Dec 2, 2024 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cheung Ivan's filings is in SPRING, TX.

Recent filings by Cheung Ivan

Jun 3, 2026: Option exercise of LXRX shares (Form 4, code M).
May 1, 2026: Grants or awards of LXRX derivative securities (2 lines, Form 4, code A).
Jun 3, 2025: Grants or awards of LXRX derivative securities (2 lines, Form 4, code A).
Dec 2, 2024: Grant or award of LXRX derivative securities (Form 4, code A).

Other insiders filing for LEXICON PHARMACEUTICALS, INC. (LXRX)

Swain Judith L, Director
Sullivan Diane E., Director
SOBECKI CHRISTOPHER J, Director
BARKER SAM L, Director
Amouyal Philippe, Director
DEBBANE RAYMOND, Director

How to read Form 4 transaction codes